Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia-Reference-Cited by-同舟云学术

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

Published:2008-04 Issue:16 Volume:51 Page:1564-1572
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Guyton John R.,Brown B. Greg,Fazio Sergio,Polis Adam,Tomassini Joanne E.,Tershakovec Andrew M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

2. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update;Smith;J Am Coll Cardiol,2006

3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002

4. Present-day uses of niacin: effects on lipid and non-lipid parameters;Sanyal;Expert Opin Pharmacother,2001

5. Should both HDL-C and LDL-C be targets for lipid therapy?;Brown;J Clin Lipidol,2007

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis;Nutrition & Metabolism;2024-06-24

2. Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update;Atherosclerosis;2022-02

3. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology;Polypharmacology;2022

4. The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential;Genes & Diseases;2021-04

5. NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death;Frontiers in Physiology;2020-08-13